Twenty DNA samples extracted from 16 blood samples and 4 tumour samples from 17 patients with known germline BRCA1 or BRCA2 copy number events, originally detected by MLPA, were used to assess the analytical sensitivity for detection of germline exonic deletions and duplications by the developed MLPA-seq method. This evidence concerns the gene BRCA1 and neoplasm.